ZURZUVAE (zuranolone) CIV, a landmark treatment for women with postpartum Depression, available in the U.S.
On Dec. 14, 2023, Biogen and Sage Therapeutics announced ZURZUVAE (zuranolone) 50 mg (two 25 mg capsules per…
Scientists unveiled complete cell map of a whole mammalian brain
On Dec. 13, 2023, for the first time ever, an international team of researchers announced they had created…
Using next-gen CRISPR tool, Gladstone scientists created unprecedented molecular map of human immune response
On Dec. 13, 2023, In a study of historic scale, scientists at Gladstone Institutes announced that they had…
Allen Institute scientists and partners unveiled first complete cellular map of adult mouse brain
On Dec. 13, 2023, the Allen Institute and collaborators announced that after six years and 32 million cells,…
Biotechnology | CRISPR | FDA | Genomics | Life Science News | Therapeutics
Vertex and CRISPR Therapeutics announced U.S. FDA approval of CASGEVY for treatment of sickle Cell disease
On Dec. 8, 2023, Vertex Pharmaceuticals and CRISPR Therapeutics announced that the U.S. Food and Drug Administration (FDA)…
bluebird bio announced commercial launch of LYFGENIA’ gene therapy for patients ages 12 and older with sickle cell disease
On Dec. 8, 2023, bluebird bio announced the U.S. commercial launch of its LYFGENIA’ (lovotibeglogene autotemcel, also known…
The University of Virginia broke ground on Paul and Diane Manning Institute of Biotechnology
On Dec. 8, 2023, the University of Virginia broke ground Friday on the Paul and Diane Manning Institute…
Anixa Biosciences and Cleveland Clinic Present Positive New Data from Phase 1 Study of Breast Cancer Vaccine
On Dec. 6, 2023, Anixa Biosciences announced updated positive results from the Phase 1 clinical trial of its…
Novavax’s updated COVID-19 vaccine received Emergency Use Authorization in the Republic of Korea
On Dec. 5, 2023, Novavax announced that Health Canada had granted expanded authorization for Nuvaxovid XBB.1.5 Vaccine (Recombinant…
Biotechnology | Diagnostics | Disease | Genomics | Life Science News | Neurology | Oncology | Therapeutics
World’s largest genetic project unveiled incredible new data
On Nov. 30, 2023, in a momentous landmark for medical research, UK Biobank announced that it had unveiled…
Novavax’s updated COVID-19 vaccine received Emergency Use Authorization in the Republic of Korea
On Nov. 29, 2023, Novavax’s partner, SK bioscience, announced that Novavax’s updated COVID-19 vaccine (NVX-CoV2601) had received Emergency…
WHO announced Avian influenza A (H5N1) cases in Cambodia
On Nov. 29, 2023, the World Health Organization (WHO) announced that between 24 and 25 November 2023, the…
Novavax’s updated protein-based COVID-19 vaccine now option for all 194 WHO member states
On Nov. 28, 2023, Novavax announced that Nuvaxovid XBB.1.5 COVID-19 Vaccine (NVX-CoV2601) had been granted Emergency Use Listing…
Emergent received $75 million contract option from BARDA to procure doses of CYFENDUS (Anthrax Vaccine)
On Nov. 28, 2023, Emergent BioSolutions announced that the Biomedical Advanced Research and Development Authority (BARDA) within the…
Upsurge of respiratory illnesses reported among children in Northern China
On Nov. 23, 2023, the World Health Organization (WHO) announced that it was monitoring data from Chinese surveillance…
Vertex and CRISPR Therapeutics announced authorization of first CRISPR/Cas9 gene-edited therapy by UK MHRA for treatment of Sickle Cell Disease
On Nov. 16, 2023, Vertex and CRISPR Therapeutics announced that the United Kingdom (U.K.) Medicines and Healthcare products…
Biotechnology | Diagnostics | Life Science News | Non-Profit Research | Oncology | Therapeutics | Vaccine
CPRIT invested $63 million to bring innovative researchers and companies to Texas
On Nov. 15, 2023, the Cancer Prevention and Research Institute of Texas (CPRIT) announced that it had approved…
Mule deer tested positive for chronic wasting disease in Yellowstone National Park
On Nov. 14, 2023, Yellowstone National Park and the Wyoming Game and Fish Department (WGFD) officials confirmed the…
WHO reported Marburg virus disease outbreak in Equatorial Guinea
On Nov. 13, 2023, the World Health Organization (WHO announced that the Ministry of Health and Social Welfare…
Surgeons in New York announced world’s first eye transplant
On Nov. 10, 2023, surgeons in New York announced they had performed the first-ever whole-eye transplant in a…
CDC published first preliminary in-season flu burden estimates
On Nov. 10, 2023, the Centers for Disease Control and Prevention (CDC) estimated that from October 1, 2023,…
Rolls-Royce joined Boeing and World Energy for successful 100% sustainable aviation fuel flight
On Nov. 7, 2023, Rolls-Royce, working with Boeing and World Energy, announced that it had carried out a…
First human-like COVID-19 mouse model created
On Nov. 6, 2023, researchers at NYU Grossman School of Medicine announced they had engineered the first mice…
Novavax’s updated COVID-19 vaccine approved in the EU
On Oct. 31, 2023, Novavax announced that the European Commission had granted approval for Nuvaxovid XBB.1.5 dispersion for…
First locally acquired case of dengue in California detected in a Pasadena resident
On Oct. 30, 2023,California Department of Public Health reported The first locally acquired case of dengue in California…
Biotechnology | Diagnostics | Life Science News | Medical Device | Neurology | Non-Profit Research | Stem Cell | Therapeutics
California’s Stem Cell Agency invested more than $42.1 million in translational-stage research
On Oct. 27, 2023, the California Institute for Regenerative Medicine (CIRM) awarded $42.1 million to fund various translational…
Biological fingerprints in soil showed where diamond-containing ore is buried
On Oct. 25, 2023, University of British Columbia researchers announced they had identified buried kimberlite, the rocky home…
FDA approved PENBRAYA,the first and only vaccine for prevention of most common serogroups causing meningococcal
On Oct. 20, 2023, Pfizer announced that the U.S. Food and Drug Administration (FDA) had approved PENBRAYA (meningococcal…
Novavax received full Marketing Authorization for potype COVID-19 vaccine Nuvaxovid in UK
On Oct. 18, 2023, Novavax announced that the Medicines and Healthcare products Regulatory Agency (MHRA) in the United…
Novavax’s prototype COVID-19 vaccine Nuvaxovid received full approval in Singapore
On Oct. 18, 2023, Novavax announced that Singapore’s Health Sciences Authority (HSA) had granted full approval for Novavax’s…